<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05123430</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02328-31</org_study_id>
    <nct_id>NCT05123430</nct_id>
  </id_info>
  <brief_title>Hemodynamic Estimation of the Result of the MitraClip Technique: Interest of the Ratio of Mean Arterial Pressure (MAP) to Pressure of the Mean Left Atrium (POG) (MitraPOG)</brief_title>
  <acronym>MitraPOG</acronym>
  <official_title>Hemodynamic Estimation Per Procedure of the Result of the MitraClip Technique: Interest of the Ratio of Mean Arterial Pressure (MAP) to Pressure of the Mean Left Atrium (POG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramsay Générale de Santé</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Clinical Trial Experts Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramsay Générale de Santé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      this research is based on the hypothesis that the measurement of the ratio of mean arterial&#xD;
      pressure to mean left atrium pressure and of its evolution during the procedure, would make&#xD;
      it possible to assess the immediate success of the procedure by supplementing the results of&#xD;
      the ultrasound.&#xD;
&#xD;
      The main objective of this research is to define the percentage of improvement in the mean&#xD;
      arterial pressure / mean left atrium pressure ratio at the end of the procedure to validate&#xD;
      the success of the MitraClip procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 23, 2021</start_date>
  <completion_date type="Anticipated">March 23, 2022</completion_date>
  <primary_completion_date type="Actual">October 19, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage improvement in the mean arterial pressure / mean left atrium pressure ratio measured at the end of the procedure.</measure>
    <time_frame>6 months</time_frame>
    <description>The percentage of improvement is defined by the value (B-A) / A * 100, with A = mean arterial pressure / mean left atrium pressure ratio at the start of the procedure and B = mean left atrium pressure / mean arterial pressure ratio at the end of the procedure.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Mitral Insufficiency</condition>
  <condition>Mitraclip</condition>
  <arm_group>
    <arm_group_label>MitraClip operated patients suffering from serious mitral insufficiency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Monitoring of the pressure of the middle left atrium</intervention_name>
    <description>During the MitraClip surgery, additional catheter is installed in order to monitoring the ppressure of the middle left atrium</description>
    <arm_group_label>MitraClip operated patients suffering from serious mitral insufficiency</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Woman or man over 18 years old&#xD;
&#xD;
          -  Patient with symptomatic mitral leakage (grade 3+ or 4+) at high surgical risk defined&#xD;
             as:&#xD;
&#xD;
               -  Age ≥ 75 years and an STS score ≥ 6%, or, according to MVARC, at least 1&#xD;
                  fragility index or at least 1 organ fragility criterion or at least 1 operative&#xD;
                  risk criterion. MVARC recommendations are defined in the appendix.&#xD;
&#xD;
               -  Age &lt;75 years and an STS score&gt; 8%, or, according to MVARC, at least 1 fragility&#xD;
                  index or at least 1 organ fragility criterion or at least 1 operative risk&#xD;
                  criterion. MVARC recommendations are defined in the appendix.&#xD;
&#xD;
               -  Patient rejected for surgery.&#xD;
&#xD;
          -  Patient with a life expectancy of over 1 year.&#xD;
&#xD;
          -  Patient affiliated or beneficiary of a social security scheme.&#xD;
&#xD;
          -  Patient having been informed and having signed a written consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with unfavorable ultrasound parameters (for example: patient with insufficient&#xD;
             mitral surface).&#xD;
&#xD;
          -  Patient with recent or active infection.&#xD;
&#xD;
          -  Patient with a contraindication to the transseptal puncture.&#xD;
&#xD;
          -  Patient with valve anatomy incompatible with the placement of the device.&#xD;
&#xD;
          -  Patient with an anomaly of the tricuspid valve justifying a surgical intervention.&#xD;
&#xD;
          -  Patient who has had a percutaneous cardiovascular procedure within the previous 30&#xD;
             days.&#xD;
&#xD;
          -  Patient who had heart surgery in the previous 30 days.&#xD;
&#xD;
          -  Patient with a history of surgery on the mitral valve.&#xD;
&#xD;
          -  Patient having had a stroke in the previous 30 days.&#xD;
&#xD;
          -  Patient participating in another clinical study.&#xD;
&#xD;
          -  Protected patient: adult under guardianship, curatorship or other legal protection,&#xD;
             deprived of liberty by judicial or administrative decision.&#xD;
&#xD;
          -  Pregnant, breastfeeding or parturient woman.&#xD;
&#xD;
          -  Patient hospitalized without consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Oudet</last_name>
    <phone>0683346567</phone>
    <email>jf.oudet@ecten.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Hélène Barba</last_name>
    <email>mh.barba@ecten.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Médipôle Hôpital Privé</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier CHAMPAGNAC, Dr</last_name>
      <phone>06 82 99 32 64</phone>
      <email>dchampagnac@cardiopole.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 9, 2021</study_first_submitted>
  <study_first_submitted_qc>November 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

